Paloma Bragado

4.4k total citations · 1 hit paper
48 papers, 3.1k citations indexed

About

Paloma Bragado is a scholar working on Molecular Biology, Oncology and Cancer Research. According to data from OpenAlex, Paloma Bragado has authored 48 papers receiving a total of 3.1k indexed citations (citations by other indexed papers that have themselves been cited), including 24 papers in Molecular Biology, 23 papers in Oncology and 8 papers in Cancer Research. Recurrent topics in Paloma Bragado's work include Cancer Cells and Metastasis (17 papers), Liver physiology and pathology (6 papers) and Melanoma and MAPK Pathways (5 papers). Paloma Bragado is often cited by papers focused on Cancer Cells and Metastasis (17 papers), Liver physiology and pathology (6 papers) and Melanoma and MAPK Pathways (5 papers). Paloma Bragado collaborates with scholars based in Spain, United States and France. Paloma Bragado's co-authors include Julio A. Aguirre‐Ghiso, María Soledad Sosa, Almudena Porrás, Yeriel Estrada, Augusto Silva, Falguni Parikh, Denis M. Schewe, Alvaro Avivar‐Valderas, Álvaro Gutiérrez-Uzquiza and Sarah Krause and has published in prestigious journals such as Journal of Biological Chemistry, Nature Medicine and Nature Communications.

In The Last Decade

Paloma Bragado

45 papers receiving 3.1k citations

Hit Papers

Mechanisms of disseminate... 2014 2026 2018 2022 2014 250 500 750

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Paloma Bragado Spain 21 1.7k 1.5k 956 415 404 48 3.1k
Anushka Dongre United States 11 1.8k 1.1× 2.0k 1.4× 1.2k 1.2× 336 0.8× 485 1.2× 15 3.8k
Cristina Nadal Spain 17 2.3k 1.4× 2.2k 1.5× 1.3k 1.3× 283 0.7× 726 1.8× 42 4.3k
Emily T. Mirek United States 15 2.5k 1.5× 1.6k 1.1× 1.0k 1.1× 467 1.1× 308 0.8× 29 3.7k
Zhenhe Suo Norway 32 1.3k 0.8× 1.8k 1.2× 872 0.9× 290 0.7× 447 1.1× 107 3.1k
Anurag Singh United States 19 2.2k 1.3× 2.8k 1.9× 1.1k 1.2× 407 1.0× 610 1.5× 42 4.3k
Go J. Yoshida Japan 21 931 0.6× 1.5k 1.0× 949 1.0× 201 0.5× 313 0.8× 25 2.5k
J. Chuck Harrell United States 35 1.8k 1.1× 1.9k 1.3× 1.1k 1.2× 214 0.5× 467 1.2× 78 3.6k
Ya’an Kang United States 31 1.4k 0.9× 2.2k 1.5× 1.7k 1.7× 366 0.9× 255 0.6× 53 3.9k
Dimitris Athineos United Kingdom 26 1.2k 0.8× 2.6k 1.8× 996 1.0× 330 0.8× 212 0.5× 36 3.7k
Jonathan A. Pachter United States 32 1.7k 1.0× 2.4k 1.6× 664 0.7× 612 1.5× 507 1.3× 137 4.4k

Countries citing papers authored by Paloma Bragado

Since Specialization
Citations

This map shows the geographic impact of Paloma Bragado's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Paloma Bragado with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Paloma Bragado more than expected).

Fields of papers citing papers by Paloma Bragado

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Paloma Bragado. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Paloma Bragado. The network helps show where Paloma Bragado may publish in the future.

Co-authorship network of co-authors of Paloma Bragado

This figure shows the co-authorship network connecting the top 25 collaborators of Paloma Bragado. A scholar is included among the top collaborators of Paloma Bragado based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Paloma Bragado. Paloma Bragado is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Valdecantos, M. Pilar, Ángela M. Valverde, Ángel M. Cuesta, et al.. (2025). Platelet C3G protects from liver fibrosis, while enhancing tumor growth through regulation of the immune response. The Journal of Pathology. 265(4). 502–517.
2.
Gutiérrez-Uzquiza, Álvaro, Paloma Bragado, Michael March, et al.. (2025). N-Acetylcysteine for Hereditary Cystatin C Amyloid Angiopathy. JAMA Neurology. 82(5). 486–486.
3.
León, Xavier, Cristina Valero, Gemma Fuster, et al.. (2024). Predictive capacity for local disease control of neogenin-1 (NEO1) transcriptional expression in patients with head and neck squamous cell carcinoma. Clinical & Translational Oncology. 27(1). 160–165.
4.
Gascón, Pere, et al.. (2024). Role of semaphorins, neuropilins and plexins in cancer progression. Cancer Letters. 606. 217308–217308. 7 indexed citations
5.
Bakhshandeh, Sadra, Adithi R. Varadarajan, Xin Lü, et al.. (2024). Dormancy-inducing 3D engineered matrix uncovers mechanosensitive and drug-protective FHL2-p21 signaling axis. Science Advances. 10(45). eadr3997–eadr3997. 8 indexed citations
6.
Cuesta, Ángel M., Paloma Bragado, Álvaro Gutiérrez-Uzquiza, et al.. (2023). New and Old Key Players in Liver Cancer. International Journal of Molecular Sciences. 24(24). 17152–17152. 13 indexed citations
7.
Díaz‐Valdivia, Natalia, Marta Gabasa, Evette S. Radisky, et al.. (2022). Aberrant TIMP-1 overexpression in tumor-associated fibroblasts drives tumor progression through CD63 in lung adenocarcinoma. Matrix Biology. 111. 207–225. 22 indexed citations
8.
Avilés‐Jurado, Francesc Xavier, Isabel Vilaseca, Ximena Terra, et al.. (2022). Semaphorin-3F/Neuropilin-2 Transcriptional Expression as a Predictive Biomarker of Occult Lymph Node Metastases in HNSCC. Cancers. 14(9). 2259–2259. 7 indexed citations
9.
Bragado, Paloma, et al.. (2022). Germline gain‐of‐function MMP11 variant results in an aggressive form of colorectal cancer. International Journal of Cancer. 152(2). 283–297. 5 indexed citations
10.
Roncero, Cesáreo, Julián Sanz‐Ortega, M. Pilar Valdecantos, et al.. (2022). Lack of EGFR catalytic activity in hepatocytes improves liver regeneration following DDC‐induced cholestatic injury by promoting a pro‐restorative inflammatory response. The Journal of Pathology. 258(3). 312–324. 11 indexed citations
11.
Porrás, Almudena, et al.. (2021). Contribution of C3G and other GEFs to liver cancer development and progression. Hepatoma Research. 1 indexed citations
12.
Gutiérrez-Uzquiza, Álvaro, et al.. (2021). C3G Protein, a New Player in Glioblastoma. International Journal of Molecular Sciences. 22(18). 10018–10018. 3 indexed citations
13.
Gutiérrez-Uzquiza, Álvaro, Paloma Bragado, Patricia Jáuregui, et al.. (2021). C3G downregulation induces the acquisition of a mesenchymal phenotype that enhances aggressiveness of glioblastoma cells. Cell Death and Disease. 12(4). 348–348. 9 indexed citations
14.
Fernández‐Nogueira, Patricia, Gemma Fuster, Patricia Jáuregui, et al.. (2018). Histamine receptor 1 inhibition enhances antitumor therapeutic responses through extracellular signal-regulated kinase (ERK) activation in breast cancer. Cancer Letters. 424. 70–83. 43 indexed citations
15.
Mancino, Mario, Patricia Fernández‐Nogueira, Neus Carbó, et al.. (2018). Glucocorticoids promote transition of ductal carcinoma in situ to invasive ductal carcinoma by inducing myoepithelial cell apoptosis. Breast Cancer Research. 20(1). 65–65. 8 indexed citations
16.
Erazo, Tatiana, Mar Lorente, Patricia Fernández‐Nogueira, et al.. (2015). The New Antitumor Drug ABTL0812 Inhibits the Akt/mTORC1 Axis by Upregulating Tribbles-3 Pseudokinase. Clinical Cancer Research. 22(10). 2508–2519. 59 indexed citations
17.
Sosa, María Soledad, Paloma Bragado, & Julio A. Aguirre‐Ghiso. (2014). Mechanisms of disseminated cancer cell dormancy: an awakening field. Nature reviews. Cancer. 14(9). 611–622. 822 indexed citations breakdown →
18.
Bragado, Paloma, Yeriel Estrada, María Soledad Sosa, et al.. (2012). Analysis of Marker-Defined HNSCC Subpopulations Reveals a Dynamic Regulation of Tumor Initiating Properties. PLoS ONE. 7(1). e29974–e29974. 25 indexed citations
19.
Sosa, María Soledad, Alvaro Avivar‐Valderas, Paloma Bragado, Huei‐Chi Wen, & Julio A. Aguirre‐Ghiso. (2011). ERK1/2 and p38α/β Signaling in Tumor Cell Quiescence: Opportunities to Control Dormant Residual Disease. Clinical Cancer Research. 17(18). 5850–5857. 181 indexed citations
20.
Adam, Alejandro P., Ajish George, Denis M. Schewe, et al.. (2009). Computational Identification of a p38SAPK-Regulated Transcription Factor Network Required for Tumor Cell Quiescence. Cancer Research. 69(14). 5664–5672. 129 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026